Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Q1 2017 · 10-Q
Revenue$2.81B$2.81B+3.1% vs Q1 2016 Net Income$747.60M$747.60M−23.0% vs Q1 2016 EPS Diluted$3.46$3.46−21.9% vs Q1 2016 Gross Profit$2,426,100,000+0.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
Operating Cash Flow$235,200,000−76.8% Free Cash Flowderived$25,200,000−97.2% Margins · derivedGross margin86.3%−2.2 pt vs Q1 2016
Operating margin36.5%−14.1 pt vs Q1 2016
Net margin26.6%−9.0 pt vs Q1 2016
ended Mar 31, 2017 · filed Apr 25, 2017 · 25 d after period end